Term ends Sep 9, 2027 · High confidence
20-year base term ended Jun 23, 2026
Held by Aegis Therapeutics, LLC
Filed Jan 27, 2009 as application 12/360,758 · Granted Mar 13, 2012
Base term plus 443 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Jun 23, 2006
Jun 23, 2006
Term ends
Sep 9, 2027
Sep 9, 2027
Granted
Mar 13, 2012
Mar 13, 2012
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
443
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 443 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 23, 2006, when application 11/474,055, the earliest non-provisional in its chain, was filed (this one was filed Jan 27, 2009) | Jun 23, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +443 days, USPTO patent term adjustment record | Sep 9, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 9, 2027 | High confidence |
This family
| US 7,425,542 | Term ended Jun 2026 | Jun 2026 |
| US 8,076,290 | In force no later than Feb 2028 | no later than Feb 2028 |
| US 8,084,022 | In force no later than Apr 2027 | no later than Apr 2027 |
| US 7,998,927 | Term ended Nov 2026 | Nov 2026 |
| US 8,133,863 | this patent Sep 2027 | Sep 2027 |
| US 8,173,594 | In force no later than May 2027 | no later than May 2027 |
| US 8,226,949 | In force Jun 2027 | Jun 2027 |
| US 8,772,231 | Term ended Aug 2026 | Aug 2026 |
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 7, 2020 Reel 54565, frame 769 | Maggio, Edward T. | Aegis Therapeutics, LLC | Assignment of Assignor's Interest |
| Aug 6, 2021 Reel 57111, frame 242 | Neurelis, Inc.; Aegis Therapeutics, LLC | Orbimed Royalty & Credit Opportunities III, LP | Security Interest |
| Nov 14, 2024 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Neurelis, Inc. | Release of Security Interest |
| Nov 14, 2024 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Aegis Therapeutics, LLC | Release of Security Interest |
| Nov 14, 2024 Reel 69359, frame 921 | Orbimed Royalty & Credit Opportunities III, LP | Neurelis, Inc.; Aegis Therapeutics, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Sep 2027
Term ends Sep 9, 2027. No further fees fall due before then
Note
The 443 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
32
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.